The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Molecular Medicine
PreviousPrevious
Volume 333:42-44 July 6, 1995 Number 1
NextNext

Jumping Genes and the Immunoglobulin V Gene System

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Multiple myeloma begins when one B cell of approximately 10 billion in the body undergoes mutations that enable it to outgrow most other cells in the bone marrow. When the neoplastic clone consists of 1011 B cells, serum electrophoresis barely detects the clone's signature molecule, a monoclonal immunoglobulin; with 1012 members, the gammopathy is unmistakable; and with 1013 myeloma cells, symptoms begin to appear. Not the least of the clinical problems in patients with myeloma is susceptibility to bacterial infection, a paradox given the huge amounts of gamma globulin secreted by the tumor. But most of the antibodies in the . . . [Full Text of this Article]

Recommended Reading


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.